Increasing anticholinergic burden and delirium in palliative care inpatients

Palliative Medicine

Volumn 28, Issue 4, 2014, Pages 335-341

  Zimmerman, Kristin M ^a,b   Salow, Marci ^b   Skarf, L Michal ^b   Kostas, Tia ^b,c   Paquin, Allison ^b   Simone, Mark J ^b,c   Rudolph, James ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

aged; anticholinergic; Delirium; palliative care; psychopharmacology

Indexed keywords

OPIATE;

AGED; ANTICHOLINERGIC EFFECT; ANTICHOLINERGIC RISK SCALE; APACHE; ARTICLE; BRAIN METASTASIS; CASE CONTROL STUDY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DELIRIUM; DEMENTIA; DISEASE SEVERITY; DRUG USE; FEMALE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; QUALITY OF LIFE; RATING SCALE; RETROSPECTIVE STUDY; VERY ELDERLY; VETERAN;

AGED; ANTICHOLINERGIC; DELIRIUM; PALLIATIVE CARE; PSYCHOPHARMACOLOGY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLINERGIC ANTAGONISTS; DELIRIUM; FEMALE; HUMANS; MALE; MASSACHUSETTS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; RETROSPECTIVE STUDIES; VETERANS;

EID: 84896441490     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216314522105     Document Type: Article

References (24)

1. Inouye SK. Delirium in older persons. N Engl J Med. 2006 ; 354: 1157-1165
2. Bruera E, Bush SH, Wiley J, et al. Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer. 2009 ; 115: 2004-2012
3. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouse/caregivers, and their nurses. Psychosomatics. 2002 ; 43: 183-194
4. Pierce SF. Improving end-of-life care: gathering suggestions from family members. Nurs Forum. 1999 ; 34: 5-14
5. Singer PA, Martin DK, Keltner M. Quality end-of-life care: patients' perspectives. JAMA. 1999 ; 281: 163-168
6. Steinhausser KE, Christakis NA, Clipp EC, et al. Factors considered important at the end of life for patients, family, physicians and other care providers. JAMA. 2000 ; 284: 2476-2482
7. Morita T, Tei Y, Tsunoda J, et al. Underlying pathologies and their associations with clinical features of terminal delirium of cancer patients. J Pain Symptom Manage. 2001 ; 22: 997-1006
8. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer. Arch Intern Med. 2000 ; 160: 786-794
9. Flacker JM, Cummings V, Mach JR, et al. The association of serum anticholinergic activity with delirium in elderly medical patients. Am J Geriatr Psychiatry. 1998 ; 6: 31-41
10. Caeiro L, Ferro JM, Claro MI, et al. Delirium in acute stroke: a preliminary study of the role of anticholinergic medications. Eur J Neurol. 2004 ; 11: 699-704
11. Tune LE, Bylsma FW. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly. Int Psychogeriatr. 1991 ; 3: 397-408
12. Mach JR, Dysken MW, Kuskowski M, et al. Serum anticholinergic activity in hospitalized older persons with delirium: a preliminary study. J Am Geriatr Soc. 1995 ; 43: 491-495
13. Fox C, Richardson K, Maidment ID, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. 2011 ; 59: 1477-1483
14. Mangoni AA, van Munster BC, Woodman RJ, et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry. 2013 ; 21: 785-793
15. Agar M, Currow D, Plummer J, et al. Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches. Palliat Med. 2009 ; 23: 257-265
16. Rudolph JL, Salow MJ, Angelini MC, et al. The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008 ; 168: 508-513
17. Han L, McCusker J, Cole M, et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001 ; 161: 1099-1105
18. Lafortune G, Paquin-Lanthier G, Beausoleil M, et al. The impact of the anticholinergic load on development of delirium in elderly. Can J Neurol Sci. 2010 ; 37 (1). S47
19. Inouye SK, Leo-Summers L, Zhang Y, et al. A chart-based method for identification of delirium: validation compared with interviewer ratings using the confusion assessment method. J Am Geriatr Soc. 2005 ; 53: 312-318
20. Ouimet S, Kavanagh BP, Gottfried SB, et al. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007 ; 33: 66-73
21. Campbell N, Perkins A, Hui S, et al. Association between prescribing of anticholinergic medications and incident delirium: a cohort study. J Am Geriatr Soc. 2011 ; 59: S277 - S281
22. Gaudreau JD, Gagnon P, Harel F, et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol. 2005 ; 23: 6712-6718
23. Van Munster BC, Thomas C, Kreisel SH, et al. Longitudinal assessment of serum anticholinergic activity in delirium of the elderly. J Psychiatr Res. 2012 ; 46: 1339-1345
24. Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med. 2004 ; 18: 184-194